Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 663193
                    [Title] => FDA review backs ezetimibe and simvastatin combination
                    [Summary] => 
After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.
                    [DatePublished] => 2011-03-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

ATHEROSCLEROTIC PROCESS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 663193
                    [Title] => FDA review backs ezetimibe and simvastatin combination
                    [Summary] => 
After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.
                    [DatePublished] => 2011-03-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

FDA review backs ezetimibe and simvastatin combination

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | March 6, 2011 - 12:00am

After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone,...

Opinion